Clinical Trial Update: ABTECT - Maintenance [Phase 3]

View source ↗

Summary

ABTECT maintenance phase 3 trial for Ulcerative Colitis is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ABTECT

Snippet

Sponsor: Abivax S.A. | Conditions: Ulcerative Colitis | Phase 3 | Status: ACTIVE_NOT_RECRUITING